Stem cell therapy for Alport syndrome: the hope beyond the hype.
Gross
Oliver
O
Department of Nephrology and Rheumatology, University Hospital Gottingen, Gottingen, Germany. gross.oliver@med.uni-goettingen.de
Borza
Dorin-Bogdan
DB
Anders
Hans-Joachim
HJ
Licht
Christoph
C
Weber
Manfred
M
Segerer
Stephan
S
Torra
Roser
R
Gubler
Marie-Claire
MC
Heidet
Laurence
L
Harvey
Scott
S
Cosgrove
Dominic
D
Lees
George
G
Kashtan
Clifford
C
Gregory
Martin
M
Savige
Judy
J
Ding
Jie
J
Thorner
Paul
P
Abrahamson
Dale R
DR
Antignac
Corinne
C
Tryggvason
Karl
K
Hudson
Billy
B
Miner
Jeffrey H
JH
D000818:Animals; D001324:Autoantigens / Q000502:physiology; D024141:Collagen Type IV / Q000502:physiology; D006801:Humans; D051379:Mice; D009394:Nephritis, Hereditary / Q000209:etiology / Q000473:pathology / Q000628:therapy*; D051437:Renal Insufficiency / Q000209:etiology / Q000473:pathology / Q000517:prevention & control; D033581:Stem Cell Transplantation
D001324:Autoantigens; D024141:Collagen Type IV; C057112:type IV collagen alpha3 chain